Диссертация (1141201), страница 21
Текст из файла (страница 21)
Clinical Practice Guidelines for the Management of Sporotrichosis: 2007Update by the Infectious Diseases Society of America. // IDSA Guidelines for management ofSporotrichosis. Clin Infect Dis. 2007. - Vol. 45. - P. 1255-1265.83.Kauffman CA. Sporotrichosis. // Clin Infet Dis.1999. - Vol. 29. - P. 231-23684.Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N,Yanagi K, Yamada A, Morita O, Yoshida Y, Furuya Y, Chiba S. Inactivation of human virusesby povidone-iodine in comparison with other antiseptics.
// Dermatology. 1997. - Vol. 195. №2. - P. 29-3585.Klieber, M., Winkler, R. and Srirajaskanthan, R. Iodine Mineral Water and ItsTherapeutic Use in Health Resorts: Iodine Consumption from Natural Mineral Waters and ItsEffect on the Body. In: Preedy, V.R., Ed., Comprehensive Handbook of Iodine, Academic Press,San Diego, 2009, P.339-344.86.Kluytmans JA, Mouton JW, Van den Bergh MF, Manders MJ, Maat AP,Wagenvoort JH, Michel MF, Verbrugh HA. Reduction of surgical-site infections incardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus.
// InfectControl Hosp Epidemiol. 1996. - Vol. 17. - № 12. - P. 780-78587.URL:Kunin R. The Healing Power of Potassium Iodide: [Электронный документ] /http://www.olaloa.com/the-healing-power-of-potassium-iodide-sski.htmlобращения: 08.03.16)147(дата88.Kotz J. The gout pipeline crystallizes. // Nat Rev Drug Discov. 2012. - Vol. 1;11.- № 6.
- P. 425-42689.StudiesKumar M, Longstreth, J, 2011 Risks and Benefits of Conducting PreclinicalintheGlobalSetting:[Электронныйдокумент]/http://www.amarexcro.com/articles/docs/RAPS_Focus_Preclinical_Global_Dec2011.pdfURL:(датаобращения: 04.03.16, 19:30)90.Kusuhara M. Sporotrichosis and dematiaceous fungal skin infections.// NihonIshinkin Gakkai Zasshi.
2009. - Vol. 50. - №4. - P. 213-21791.Lacey RW, Catto A. Action of povidone-iodine against methicillin-sensitive and -resistant cultures of Staphylococcus aureus. // Postgrad Med J. 1993. - Vol. 69. - №3. - P. 78-8392.Lange N. A., Speight J. G. Lange's handbook of chemistry. – 2005.93.Lam OL, McGrath C, Bandara HM, Li LS, Samaranayake LP. Oral healthpromotion interventions on oral reservoirs of staphylococcus aureus: a systematic review.
// OralDis. 2012. - Vol. 18. - № 3. - P. 244-25494.Laurberg P, Andersen S, Pedersen IB, Knudsen N, Carlé A. Prevention ofautoimmune hypothyroidism by modifying iodine intake and the use of tobacco and alcohol ismanoeuvring between Scylla and Charybdis. // Hormones (Athens). 2013. - Vol. 12. - № 1. - P.30-3895.Leite G. Research on tuberculosis: 75 years of IBIT contributions. // Braz J InfectDis. 2013. - Vol. 17.
- № 2. - P. 205-210.96.Lipsky MS, Sharp LK. From idea to market: the drug approval process. // J AmBoard Fam Pract. 2001. - Vol. 14. - № 5. - P. 362-36797.Luo XM, Niu LZ, Chen JB, Xu KC. Advances in cryoablation for pancreaticcancer. // World J Gastroenterol. 2016. - Vol.
14;22. - №2. - P. 790-80098.Melse-Boonstra A, Mackenzie I. Iodine deficiency, thyroid function and hearingdeficit: a review.// Nutr Res Rev. 2013. - Vol. 26. - № 2. - P. 110-11799.Mendiratta V, Karmakar S, Jain A, Jabeen M. Severe cutaneous zygomycosis dueto Basidiobolusranarum in a young infant. // Pediatr Dermatol. 2012. - Vol. 29. - P. 121-123.100.Miller DW. Extrathyroidal benefits of iodine. // J Am Phys Surg. 2006. - Vol. 11.- P.
106-110.101.Mondal AK, Saha A, Seth J, Mukherjee S. Subcutaneous Zygomycosis: A Reportof One Case Responding Excellently to Potassium Iodide. // Indian J Dermatol. 2015. - Vol. 60. №5. - P. 500-502148102.Moro ML, Errante I, Infuso A, Sodano L, Gori A, Orcese CA, Salamina G,D'Amico C, Besozzi G, Caggese L. Effectiveness of infection control measures in controlling anosocomial outbreak of multidrug-resistant tuberculosis among HIV patients in Italy. // Int JTuberc Lung Dis.
2000. - Vol. 4. - №1. - P. 61-68103.Munos B. Lessons from 60 years of pharmaceutical innovation. // Nat Rev DrugDiscov. 2009. - Vol. 8. - №12. - P. 959-968;104.Müller G., Kramer A. Biocompatibility index of antiseptic agents by parallelassessment of antimicrobial activity and cellular cytotoxicity //Journal of AntimicrobialChemotherapy. – 2008. – Vol. 61. – №. 6. – P. 1281-1287.105.Mycock G. Methicillin/antiseptic-resistant Staphylococcus aureus. // Lancet.1985. - Vol. 26;2.
- № 8461. - P. 949-950106.Nunley JR, Wolverton S, Darst M. Systemic drugs. In: Bolognia JL, Jorizzo JL,Rapini RP editors. Dermatology.2nd ed. Madri: Mosby Elsevier; 2008. p. 2017-8107.Narendranath S, Sudhakar GK, Pai MR, Kini H, Pinto J, Pai MR. Safety andefficacy of oral potassium iodide in chromoblastomycosis. // Int J Dermatol. 2010. - Vol. 49. №3.
- P. 341-343108.Numata S, Numata T, Gonoi T, Matsunaga K. Successful treatment ofprimarycutaneous Nocardia brasiliensis infection with oral potassium iodide. // J Dermatol.2016.- Vol. 15109.Onouchi H, Nitta Y. Cutaneous mycobacterium chelonea subsp. infection in a ten-year-old boy. // Rinsho Derma (Tokyo) 2003. - Vol.
45. - P. 375 –377110.Outterson K, Powers JH, Seoane-Vazquez E, Rodriguez-Monguio R, KesselheimAS. Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 19802009. // J Law Med Ethics. 2013. - Vol. 41. - №3. - P. 688-696111.Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR,Schacht AL.
How to improve R&D productivity: the pharmaceutical industry's grand challenge.// Nat Rev Drug Discov. 2010. - Vol. 9. - №3. - P. 203-214112.Petruzzi M, Grassi FR, Nardi GM, Martinelli D, Serpico R, Luglie PF, Baldoni E.Sodium iodide associated to salicylic acid in the topical management of chronic oral candidiasis:a randomized trial. // J Biol Regul Homeost Agents. 2010.
- Vol. 24. - №3. - P. 381-384113.Prakash O. et al. Hypervalent iodine (III) mediated synthesis of novelunsymmetrical 2, 5-disubstituted 1, 3, 4-oxadiazoles as antibacterial and antifungal agents//European journal of medicinal chemistry. – 2010. – Vol. 45. – №. 9. – P. 4252-4257.149114.Preedy V. R., Burrow G. N., Watson R. R. (ed.). Comprehensive handbook ofiodine: nutritional, biochemical, pathological and therapeutic aspects. – Academic Press, 2009115.Projan SJ. Why is big Pharma getting out of antibacterial drug discovery? // CurrOpin Microbiol. 2003.
- Vol. 6. - № 5. - P. 427-430116.Rahn R. Review presentation on povidone-iodine antisepsis in the oral cavity. //Postgrad Med J. 1993. - Vol. 69. - № 3. - P. 4-9117.Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. // ClinDermatol. 2007. - Vol. 25. - P. 181-187.118.Rasmussen H. Iodide hypersensitivity in the etiology of periarteritis nodosa. // JAllergy 1995. - Vol. 26. - P. 394-407.119.Reimer K. et al. Antimicrobial effectiveness of povidone-iodine and consequencesfor new application areas //Dermatology.
– 2002. – Vol. 204. – №1. – P. 114-120.120.Rikimaru T, Kondo M, Kajimura K, Hashimoto K, Oyamada K, Miyazaki S,Sagawa K, Aizawa H, Oizumi K. Efficacy of common antiseptics against multidrug-resistantMycobacterium tuberculosis. // Int J Tuberc Lung Dis.
2002. - Vol. 6. - №9. - P. 763-770121.Rikimaru T, Kondo M, Kondo S, Oizumi K. Bactericidal activities of povidone-iodine against Mycobacterium. // Dermatology. 1997. - Vol. 195. - №2. - P. 104-106122.Rombaux P, Collet S, Hamoir M, Eloy P, Bertrand B, Jamart F, Gigi J. The roleof nasal cavity disinfection in the bacteriology of chronic sinusitis. // Rhinology. 2005. - Vol.
43.- № 2. - P. 125-129123.Rowland M., Tozer T.N. Clinical. pharmacokinetics. Baltimore, Philadelphia,Hong Kong and so on, 1995.;124.Ruffolo RR. Why has R&D productivity declined in the pharmaceutical industry?// Expert Opin Drug Discov. 2006. - Vol. 1. - № 2. - P. 99-102125.Sacks W, Fung CH, Chang JT, Waxman A, Braunstein GD. The effectiveness ofradioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peerreviewed literature from 1966 to April 2008. // Thyroid. 2010. - Vol.
20. - № 11. - P. 1235-1245126.Sathapatayavongs B, Leelachaikul P, Prachaktam R, Atichartakarn V,Sriphojanart S, Trairatvorakul P, Jirasiritham S, Nontasut S, Eurvilaichit C, Flegel T. Humanpythiosis associated with thalassemia hemoglobinopathy syndrome. // J Infect Dis. 1989. - Vol.159. - №2.
- P. 274-280127.Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline inpharmaceutical R&D efficiency. // Nat Rev Drug Discov. 2012. - Vol. 1;11. - №3. - P. 191-200150128.Senska G, Rüsing D. The treatment of MRSA colonized middle ear; case reportand literature review. // Laryngorhinootologie. 2010. - Vol. 89. - №7. - P.
404-408.129.Shelley WB. Generalized pustular psoriasis induced by potassium iodide: Apostulated role for dihydrofolatec reductase. // JAMA 1967. - Vol. 201. - P. 1009-14.56.130.ShinodaN.etal.Disinfectant-susceptibilityofmulti-drug-resistantMycobacterium tuberculosis isolated in Japan //Antimicrobial resistance and infection control. –2016. – Vol. 5. – №.
1. – P. 1.131.Shirai T, Tsuchiya H, Nishida H, Yamamoto N, Watanabe K, Nakase J, TerauchiR, Arai Y, Fujiwara H, Kubo T. Antimicrobial megaprostheses supported with iodine. // JBiomater Appl. 2014. - Vol. 29. - №4. - P. 617-623132.Silver LL. Challenges of antibacterial discovery. // Clin Microbiol Rev. 2011. -Vol. 24. - № 1. - P. 71-109133.Sircus M. Iodine. – Lulu Press, Inc, 2015.134.Sirén EK, Haapasalo MP, Waltimo TM, Ørstavik D. In vitro antibacterial effectof calcium hydroxide combined with chlorhexidine or iodine potassium iodide on Enterococcusfaecalis. // Eur J Oral Sci. 2004. - Vol. 112.
- №4. - P. 326-331135.Sobotka L., Velebny V., Ruzickova J., Slemrova M., Zadak Z. The treatment ofcomplete sternal dehiscence with a combination of sodium hyaluronate and an iodine complex.In: Balaz E.A. Hasal V.C. Ed. Hyaluronan structure, metabolism, biological activities.therapeutic applications. // Edgewater(NJ): Matrix Biology Institute; 2005. - P. 843-845.136.Spangberg L, Engstrom B, Langeland K.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
